Good Health Can’t Wait.

More documents

Recommendations

Info

Good Health Can’t Wait. Dr. Reddy’s Laboratories Limited NOTES TO FINANCIAL STATEMENTS (All amounts in Indian Rupees millions, except share data and where otherwise stated) 2.30: EMPLOYEE STOCK OPTION SCHEME (CONTINUED) Stock option activity under the DRL 2002 Plan for the two categories of options was as follows: CATEGORY A – FAIR MARKET VALUE OPTIONS YEAR ENDED 31 MARCH 2015 PARTICULARS SHARES ARISING OUT OF OPTIONS RANGE OF EXERCISE PRICES WEIGHTED-AVERAGE EXERCISE PRICE WEIGHTED- AVERAGE REMAINING CONTRACTUAL LIFE (MONTHS) Outstanding at the beginning of the year 10,000 ` 448.00 ` 448.00 44 Granted during the year - - - - Expired / forfeited during the year - - - - Exercised during the year (10,000) ` 448.00 ` 448.00 - Outstanding at the end of the year - - - - Exercisable at the end of the year - - - - CATEGORY A – FAIR MARKET VALUE OPTIONS YEAR ENDED 31 MARCH 2014 PARTICULARS SHARES ARISING OUT OF OPTIONS RANGE OF EXERCISE PRICES WEIGHTED-AVERAGE EXERCISE PRICE WEIGHTED- AVERAGE REMAINING CONTRACTUAL LIFE (MONTHS) Outstanding at the beginning of the year 11,000 ` 373.50-448.00 ` 441.23 52 Granted during the year - - - - Expired / forfeited during the year (1,000) ` 373.50 ` 373.50 - Exercised during the year - - - - Outstanding at the end of the year 10,000 ` 448.00 ` 448.00 44 Exercisable at the end of the year 10,000 ` 448.00 ` 448.00 44 CATEGORY B – PAR VALUE OPTIONS YEAR ENDED 31 MARCH 2015 PARTICULARS SHARES ARISING OUT OF OPTIONS RANGE OF EXERCISE PRICES WEIGHTED-AVERAGE EXERCISE PRICE WEIGHTED- AVERAGE REMAINING CONTRACTUAL LIFE (MONTHS) Outstanding at the beginning of the year 641,674 ` 5.00 ` 5.00 78 Granted during the year 230,840 5.00 5.00 90 Expired / forfeited during the year (59,148) 5.00 5.00 - Exercised during the year (227,912) 5.00 5.00 - Outstanding at the end of the year 585,454 ` 5.00 ` 5.00 71 Exercisable at the end of the year 43,425 ` 5.00 ` 5.00 40 CATEGORY B – PAR VALUE OPTIONS YEAR ENDED 31 MARCH 2014 PARTICULARS SHARES ARISING OUT OF OPTIONS RANGE OF EXERCISE PRICES WEIGHTED-AVERAGE EXERCISE PRICE WEIGHTED- AVERAGE REMAINING CONTRACTUAL LIFE (MONTHS) Outstanding at the beginning of the year 684,259 ` 5.00 ` 5.00 71 Granted during the year 258,870 5.00 5.00 90 Expired / forfeited during the year (60,315) 5.00 5.00 - Exercised during the year (241,140) 5.00 5.00 - Outstanding at the end of the year 641,674 ` 5.00 ` 5.00 78 Exercisable at the end of the year 50,818 ` 5.00 ` 5.00 42 148
Standalone Financial Statements Annual Report 2014 - 15 NOTES TO FINANCIAL STATEMENTS (All amounts in Indian Rupees millions, except share data and where otherwise stated) 2.30: EMPLOYEE STOCK OPTION SCHEME (CONTINUED) Dr. Reddy’s Employees ADR Stock Option Plan-2007 (“the DRL 2007Plan”): The Company instituted the DRL 2007Plan for all eligible employees in pursuance of the special resolution approved by the shareholders in the Annual General Meeting held on 27 July2005. The DRL 2007 Plan came into effect on approval of the Board of Directors on 22 January2007. The DRL 2007 Plan covers all employees of DRL and its subsidiaries and directors (excluding promoter directors) of DRL and its subsidiaries (collectively, “eligible employees”). Under the DRL 2007 Plan, the Nomination, Governance and Compensation Committee of the Board (the ‘Committee’) shall administer the DRL 2007 Plan and grant stock options to eligible employees of the Company and its subsidiaries. The Nomination, Governance and Compensation Committee shall determine the employees eligible for receiving the options, the number of options to be granted, the exercise price, the vesting period and the exercise period. The vesting period is determined for all options issued on the date of the grant. The options issued under the DRL 2007 Plan vest in periods ranging between one and four years and generally have a maximum contractual term of five years. The Committee may, after obtaining the approval of the shareholders in the Annual General Meeting, grant options with a per share exercise price other than fair market value and par value of the equity shares. During the year ended 31 March 2015, the Company has issued 45,796 Category B options to eligible employees under the DRL 2007 Plan. The vesting period for the options granted varies from 12 to 48 months. The date of grant, number of options granted, exercise price fixed by the Committee for respective options and the market price of the shares of the Company on the day prior to the date of grant is given below: DATE OF GRANT NUMBER OF OPTIONS GRANTED EXERCISE PRICE ` MARKET PRICE ` (AS PER SEBI GUIDELINES) 25 May 2014 40,096 5.00 2,308.70 15 June 2014 4,700 5.00 2,445.15 14 July 2014 1,000 5.00 2,700.70 Stock option activity under the DRL 2007 Plan was as follows: CATEGORY B – PAR VALUE OPTIONS YEAR ENDED 31 MARCH 2015 PARTICULARS SHARES ARISING OUT OF OPTIONS RANGE OF EXERCISE PRICES WEIGHTED- AVERAGE EXERCISE PRICE WEIGHTED- AVERAGE REMAINING CONTRACTUAL LIFE (MONTHS) Outstanding at the beginning of the year 97,463 ` 5.00 ` 5.00 79 Granted during the year 45,796 5.00 5.00 90 Expired / forfeited during the year (10,515) 5.00 5.00 - Exercised during the year (34,394) 5.00 5.00 - Outstanding at the end of the year 98,350 ` 5.00 ` 5.00 72 Exercisable at the end of the year 6,730 ` 5.00 ` 5.00 42 CATEGORY B – PAR VALUE OPTIONS YEAR ENDED 31 MARCH 2014 PARTICULARS SHARES ARISING OUT OF OPTIONS RANGE OF EXERCISE PRICES WEIGHTED-AVERAGE EXERCISE PRICE WEIGHTED- AVERAGE REMAINING CONTRACTUAL LIFE (MONTHS) Outstanding at the beginning of the year 98,608 ` 5.00 ` 5.00 73 Granted during the year 44,240 5.00 5.00 90 Expired / forfeited during the year (14,132) 5.00 5.00 - Exercised during the year (31,253) 5.00 5.00 - Outstanding at the end of the year 97,463 ` 5.00 ` 5.00 79 Exercisable at the end of the year 7,265 ` 5.00 ` 5.00 44 The Company has not granted any options under Category A of “the DRL 2007 Plan”. The Company has followed intrinsic method of accounting based on which a compensation expense of `519 (previous year: `472) has been recognized in the statement of profit and loss. 149
Page 1 and 2:
ANNUAL REPORT 2014-15 Good Health C
Page 3 and 4:
Our Brand We are in the business of
Page 5 and 6:
Corporate Overview Annual Report 20
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Statutory Reports • Business Resp
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Statutory Reports • Management Di
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Statutory Reports • Corporate Gov
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Statutory Reports • Additional Sh
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Statutory Reports • Board’s Rep
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100: Statutory Reports • Board’s Rep
Page 111 and 112: Standalone Financial Statements Ann
Page 149: Standalone Financial Statements Ann
Page 165 and 166: Consolidated Financial Statements A
Page 201 and 202:
Consolidated Financial Statements A
Page 203 and 204:
Page 205 and 206:
Page 207 and 208:
Page 209 and 210:
Page 211 and 212:
Page 213 and 214:
Page 215 and 216:
Page 217 and 218:
Page 219 and 220:
Page 221 and 222:
Page 223 and 224:
Page 225 and 226:
Page 227 and 228:
Notice Annual Report 2014 - 15 NOTI
Page 229 and 230:
E-Voting Annual Report 2014 - 15 IN
Page 231:
Dr. Reddy’s Laboratories Limited
Page 235 and 236:
The future belongs, not to those wh
show all

Good Health Can’t Wait.

Create successful ePaper yourself

Delete template?

Save as template?